This paper describes a micro fluorescence in situ hybridization (µFISH)-based rapid detection of cytogenetic biomarkers on formalin-fixed paraffin embedded (FFPE) tissue sections. We demonstrated this method in the context of detecting human epidermal growth factor 2 (HER2) in breast tissue sections. This method uses a non-contact microfluidic scanning probe (MFP), which localizes FISH probes at the micrometer length-scale to selected cells of the tissue section. The scanning ability of the MFP allows for a versatile implementation of FISH on tissue sections.
I. INTRODUCTION
The most common cancer in females is breast cancer with 464'000 new cases alone in 2012, of which 131'000 cases were lethal 1 . While the breast cancer incidence rate has been increasing, the death rate has decreased by 40% since the 90ies 2 . This is likely due to early detection of the solid tumor linked to efforts in public health to improve awareness among women (at risk) and routine screening. Further, the detection of breast cancer related biomarkers through genomic and transcriptomic analysis allows reclassification of the tumors into molecular subtypes 3, 4 such as Luminal A (ER+, PR+, HER2-), Luminal B (low p53 mutation, ER+, PR+, HER2++), Basal-like (Triple-negative) or HER2++
( Fig. 1a) . Associated subtype-specific targeted therapies have led to more effective and successful treatment of patients and increased the survival rates 3, 4 .
In particular, the HER2-positive subtype is an aggressive form of breast cancer and generally associated with poor prognosis 5 . Overexpression of the HER2 membrane protein occurs in 18-20% of breast tumors 6 . Assessment of the HER2 status is therefore important to determine whether a patient qualifies for the targeted antibody-based anti-HER2
therapy, an adjuvant to standard breast cancer chemotherapy. HER2 status assessment is not only important in breast cancer but there is even evidence that HER2 testing may be beneficial in gastric 7 and gynecological 8 malignancies. IHC continues to be the 'gold standard' for HER2 testing in most diagnostic laboratories despite the bottlenecks outlined below. IHC relies on antibodies binding to the HER2 antigen on the cell membrane and their subsequent detection by a labelled secondary antibody. The samples are graded from 0 to +3 according to the staining intensity of the sample (0: no expression, +1: weak expression, +2: equivocal, and +3: high expression). Only samples scored with grade +3 qualify the patient for the targeted anti-HER2 therapy. However, approximately 20% of results obtained using IHC for HER2 testing are inaccurate 10 . IHC results are not quantitative, since the staining intensity is assessed by eye resulting in subjective grading of the tumor and thus the results often differ between different laboratories.
Techniques such as immunohistochemistry (IHC), polymerase chain reaction (PCR)
Further, loss of sensitivity secondary to antigenic alterations 11 caused by standard fixation procedures and batch-tobatch variations of the antibody 12 can alter the staining performance. In addition, staining results are often not clear and reported as equivocal. In this situation, a second test -ISH as suggested by the ASCO/CAP guidelines 10 -is needed to assess the HER2 amplification status, delaying diagnosis and requiring additional samples (Fig. 1b) .
In contrast to IHC, in situ hybridization is a cytogenetic method and, specifically for HER2 testing, relies on ISH probes, labelled nucleic acid sequences, that hybridize to the locus of the HER2 gene on chromosome 17 and the centromeric region of chromosome 17 13 , Fig. 1c . It was reported that 90-95% of breast carcinomas that overexpress HER2 do so secondary to HER2 gene amplification 14, 15 . An ISH result is positive if HER2/Cen17 ratio ≥2 or the average HER2 copy number ≥6 signals/cell, and negative if HER2/Cen17 ratio <2 according to the 2013 ASCO/CAP guidelines 10 ( Fig. 1b) . ISH is a specific method 16 and since each ISH signal represents a single copy of a gene, it is 3 considered more quantitative and accurate than standard IHC. Despite these merits of ISH, it is not a routine diagnostic procedure; it is primarily used to assess the HER2 status of the patient samples, which were reported as IHC equivocal 10 . This is the case because ISH tests are time consuming ranging from one to several days, the reagents are expensive, especially the FISH probes, and highly trained personnel are required in the diagnostic laboratories.
FIG. 1. HER-2 classification of FFPE tumor samples. (a) Preparation steps for FFPE tissues from solid tumors. (b)
Representative 
II. MATERIAL AND METHODS

A. Microfluidic probe platform
The platform comprised a standard inverted microscope, sub-micrometer precision stages, syringe pumps connected to a microfabricated silicon-glass hybrid MFP head, mounted to a custom-made z-stage ( with a cover slip and denatured at 65-72 °C for 10 min. After this step, the cover slip was removed, the slide rinsed with prewarmed 1×SSC and hybridization experiments were performed.
For benchtop FISH control experiments, the FISH probes were diluted as specified by the manufacturer's protocol in FISH buffer (KBI-FHB). This hybridization mix was subsequently pipetted onto the pre-treated FFPE cell blocks, which were covered with a cover slip and denatured at 72°C for 10 min. After denaturation the slide was incubated fpr hybridization at 37°C overnight. After hybridization, the slides were washed 2 times to wash non-specifically 
C. FISH probe preparation and FISH probe loading into the MFP
The Cen17 probes were prepared from a mix of seven centromere 17-specific oligonucleotides with 3' and 5' Cy3 labels (SI Table S2 ), which were purchased from Integrated DNA Technologies (Coralville, Iowa). The sequences were adapted from Ref. 31 The 10× FITC-labelled HER-2 SureFISH probe was purchased from DAKO (Cat. No. For all experiments the Cen17 probes were used at a total concentration of 28 nM. The HER2 probe was diluted 1:10 in Cen17 containing EC-buffer. These FISH probes were denatured at 75 °C (formamide) or 66-68 °C (ethylene carbonate) for 5-10 min in a PCR cycler (QIAGEN, Rotor-Gene Q). To visualize the footprint indirectly, Hoechst dye was added to the probes at a concentration of 0.2 μg mL -1 (Thermo Fisher Scientific, Cat. No. H3570). Subsequently these denatured probes were pipetted into a PCR cap and from there aspirated into the inner injection aperture of the MFP head.
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D. μFISH protocol
One hour prior to performing the experiment, the environmental chamber around the MFP platform was heated to 45°C. After FISH probe loading into the MFP head, the pre-treated sample was transferred to the sample holder of the 
III. RESULTS
A. Oligo-based probes for chromosomal enumeration in FFPE tissue sections with <5 min incubation
We aimed to enumerate the copy numbers of chromosome 17 in FFPE tissue sections, and for this we adapted the MFP-based FISH method 29 . In contrast to the 'fresh' cells we used for our previous study, FFPE samples undergo a series of preparation steps affecting the sample integrity [32] [33] [34] [35] [36] [37] [38] . Formaldehyde fixation of cytological samples is associated with DNA modifications 32 , DNA fragmentation 33 and DNA-protein crosslinking 34 , which affects the DNA integrity. Further, the crosslinked matrix can reduce the FISH probe mobility, i.e. the FISH probe penetration through the sample and the target accessibility, thereby lowering the efficiency in hybridization of probes to the target. To enable rapid FISH-based chromosomal enumeration on FFPE tissue sections, we: (i) adapted the FISH probe and moved to using short oligonucleotides, and (ii) optimized the composition of the hybridization buffer. DNA mobility in the cell and cell nucleus decreases as the length of the DNA increases 39 . Similarly, the mobility of FISH probes in the cell decreases with increasing length and thus it has been found that an optimal length for oligonucleotide FISH probes is 18-50 nucleotides (nt) 40 . Longer probes will result in increased hybridization times and low synthesis yields; on the other hand, shorter probes will result in reduced specificity 40 . To yield rapid FISH we therefore used 18 nt long oligonucleotide probes as the Cen17 probe (Table SI, (Fig. 3) . Thus, the short DNA FISH probes are characterized with a high mobility through the crosslinked matrix. In addition, the hybridization process itself is likely accelerated by the change of hybridization buffer to the formamide-free composition. Formamide is a denaturation agent, which interferes with the hydrogen bonds forming during hybridization 41 , thereby slowing down the hybridization.
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FIG. 3. µFISH-based chromosomal enumeration in FFPE tumor sections (i) In situ hybridization occurs only in the cell nuclei (blue) within the area of the flow confinement (green). The tear shape is caused by the asymmetry between the injection and aspiration rate (i,ii). Fluorescent micrographs of Cen17 FISH signals (green) before (ii) and after image processing (iii,iv).
B. µFISH-based HER2 testing for diagnosis of breast cancer tissue sections.
We then posed the question, whether this MFP-based method can be used in a diagnostic context, for HER2 testing on FFPE cell blocks and tissue sections. To achieve this, we used a mix of oligo-based HER2 and Cen17 probes.
However, HER2-specific probes did not create FISH signals within 5 min incubation with MFP-based FISH on FFPE samples, when diluted in in 1 SSC. The chosen HER2 probes are commercially available synthetic oligonucleotide probes and specifically designed to the HER2 locus 42 . Cen17 FISH probes bind repetitive elements of chromosome 17 and each probe sequence has ~100 targets per chromosome. In contrast, the HER2 locus contains fewer repetitive elements and each HER2-specific probe sequence binds a unique target within the HER2 locus. Thus, the probability of a Cen17 finding its target is higher than the probability of a HER2 probe finding its target. Further, HER2 probes used here are long oligonucleotide probes 42, 43 with a length of ~ 150 nt. Since DNA mobility is reduced with increasing length 39 , the HER2 probes require more time for hybridization than the 18 nt Cen17 probe.
To accelerate the hybridization reaction, we therefore modified the buffer by adding dextran sulfate as a volume exclusion agent 44 and ethylene carbonate (EC), adapted from the Instant Quality (IQ) FISH method 28 . Performing FISH probe incubation of the probe mix in EC-buffer using the MFP, we were able to assess the HER2 status of both FFPE cell blocks and breast cancer tissue sections within 10 min (cells) and 15 min (tissue) incubation time ( Fig. 4.a,b) . Even at flow rates of 7 nL min -1 we were able to establish a stable flow confinement. Further, since the probe mix is viscous, the flow confinement was still in contact with the cells at these low flow rates and a surface-to-apex distance d = 20 µm. After less than one minute, the Cen17 signals were saturated and HER2 signals appeared within 15 min incubation (Fig. 4.a,b) .
We specifically chose MCF-7 (HER2 negative) and BT-474 (HER2 positive) cell blocks for validation of the MFPbased FISH method and quantified the HER2/Cen17 ratios in 20 cells as recommended by the ASCO/CAP guidelines after both benchtop FISH using a pipette and µFISH experiments (Fig. S4 , supplementary material for fluorescent micrographs after benchtop experiments). The HER2/Cen17 ratios calculated for both on-bench and MFP-based FISH were experiments were comparable for as illustrated in the graph in Fig. 4 .c. The ratio was 0.82 (MFP) and 0.64 (benchtop) in MCF-7 cells and in BT-474 cells, the ratio was 2.8 (MFP) and 3.0 (benchtop).
In addition, we tested the µFISH method on FFPE tissue sections and assessed the HER2/Cen17 ratio in 20 cells from two tissue cores from a tissue microarray. As depicted in Fig. 4 .d the HER2 status assessed with µFISH matched the IHC data of the datasheet from the tissue microarray.
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FIG. 4. µFISH-based HER2 assessment in FFPE cell blocks and tumor sections. (a) Fluorescent micrographs for qualitative validation of µFISH for HER2 assessment on HER2 amplifying (BT-474) and HER2 non-amplifying (MCF-7) FFPE cell blocks. (b) Validation of µFISH-based HER2 assessment on nuclei (outlined) of HER2-amplified (left) and HER2 non-amplified (right) FFPE invasive ductal carcinoma tissue cores from a tissue microarray. (c) HER2/Cen17 ratios in MCF-7 and BT-474 cells in FFPE cell blocks assessed with benchtop and MFP-based FISH. Error bars present the standard error of the mean for n=20 measurements. (d) Quantified HER2/Cen17 ratio from 20 cells of the tissue cores illustrated in (b) comparing to the HER2 status from the tissue microarray datasheet.
C. FISH probe recirculation for efficient use of FISH probes
For a more economic use of FISH probes, we tested the concept of recirculation on FFPE cell blocks. In a classical flow confinement, a processing liquid is confined between two apertures at the apex of the MFP head and the surface, in the presence of an immersion liquid. Since the aspiration rate is set to be approximately 3-fold higher than the injection rate to ensure a stable flow confinement, immersion liquid will be aspirated together with the processing liquid into the aspiration channel, resulting in an ~3-fold dilution of the processing liquid. The addition of two extra apertures, allows the processing liquid to be nested within a confinement of a second liquid, resulting in a hierarchical flow confinement 46 . Specifically, for MFP-based FISH, in a hierarchical hydrodynamic flow confinement the FISH probes are confined between the inner two apertures, while between the outer two apertures, a wash buffer is confined to nest the FISH probes (Fig. 5a ). Since the outer aspiration rate is high with Qa2>>Qa1 and maintains a stable flow confinement, the inner injection and aperture rates can be set to Qi2=|Qa1|. Due to this symmetry between Qi2 and Qa1, a liquid injected with Qi2 is aspirated by Qa1 with minimal dilution. Therefore, a liquid confined between the inner two apertures can be re-injected and thus recirculated after inversion of the flow rates: Qi2↔Qa1, Qi1↔Qa2 (Fig. 5 ).
The graph in Fig. 5b illustrates the probe dilution per recirculation cycle for 1 µL of Cen17 probes in 1 SSC with a probe injection rate Qi2 of 0.2 µL min -1 , 5 min switching intervals and a surface-to-apex distance d = 20 µm. We measured the fluorescence intensity for each recirculation cycle and normalized the intensity with respect to the initial fluorescence intensity of the confined probes. As illustrated in Fig. 5b , the FISH probes are diluted by ~ 6% per recirculation cycle. This dilution is likely due to the slight asymmetry of the flow profile resulting in a small flow from the immersion liquid into the inner aspiration aperture and the loss of FISH probes aspirated into the outer aspiration aperture. We next investigated the possibility of using a small volume of FISH probes for multiple FISH tests. In a proof-of- 
IV. DISCUSSION
Operating at flow rates of 7 nL min In the MFP-based FISH implementation, convection-based delivery of reactants accelerates the reaction by enhancing the mass transport; the reagent consumption is, however, dependent on the reaction duration, because the incubation step is flow-based. To overcome this, we made use of the capability of the MFP to recirculate liquids and demonstrated 14 that a finite volume of FISH probes can be recycled, and the probes are used more efficiently. Recirculation of probes has several advantages. It allows multiple areas of a heterogeneous sample or multiple samples to be probed using one volume of probes. Further, even slow-hybridizing FISH probes such as long FISH probes of > 500 nt can now be hybridized with the MFP without increasing the probe consumption.
V. CONCLUDING REMARKS
We introduced methods and protocols for rapid detection of an important breast cancer biomarker, human epidermal growth factor receptor 2 (HER2), in tissue sections. We make use of a microfluidic probe technology and perform localized FISH probe incubation with cells in selected regions of tissue sections and cell blocks. This is done by confining FISH probes hydrodynamically on the tissue section at the micrometer length-scale without needing to construct physical walls. By using minimal probe amounts and also minimal amounts of the scarce cytological sample, the MFP-based FISH implementation presents a valuable method for diagnosis of breast cancer biopsies.
The focus of this work was to overcome the rate-limiting step in FISH, the probe hybridization, by using an MFP.
However, combining recently reported features for liquid heating 47 and liquid switching 48 Going forward we expect to adapt the method for multiplexed RNA FISH for research applications using branched RNA probes. The recently developed RNA ISH methods revealed new biomarkers, which may become diagnostic or prognostic markers in the future [52] [53] [54] . Overall, µFISH supports our vision of tissue microprocessing to implement several bio-analytical tests on limited biopsy samples.
SUPPLEMENTARY MATERIAL
See supplementary material for further information on the MFP platform, image processing with ImageJ, bench-top FISH controls and Cen17 probe sequences.
